HRT Financial’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-92,926
| Closed | -$1.71M | – | 2211 |
|
|
2024
Q4 | $1.71M | Buy |
92,926
+40,558
| +77% | +$744K | 0.01% | 692 |
|
|
2024
Q3 | $805K | Sell |
52,368
-123,451
| -70% | -$1.9M | ﹤0.01% | 1256 |
|
|
2024
Q2 | $2.86M | Buy |
175,819
+141,756
| +416% | +$2.3M | 0.02% | 568 |
|
|
2024
Q1 | $629K | Sell |
34,063
-276,499
| -89% | -$5.11M | ﹤0.01% | 1082 |
|
|
2023
Q4 | $9.72M | Buy |
310,562
+281,165
| +956% | +$8.8M | 0.07% | 156 |
|
|
2023
Q3 | $612K | Buy |
+29,397
| New | +$612K | 0.01% | 1156 |
|
|
2023
Q2 | – | Sell |
-257,237
| Closed | -$4.84M | – | 2165 |
|
|
2023
Q1 | $4.84M | Buy |
+257,237
| New | +$4.84M | 0.06% | 255 |
|
|
2022
Q3 | – | Sell |
-55,918
| Closed | -$787K | – | 2516 |
|
|
2022
Q2 | $787K | Buy |
55,918
+14,020
| +33% | +$197K | 0.01% | 1069 |
|
|
2022
Q1 | $1.01M | Sell |
41,898
-92,531
| -69% | -$2.24M | 0.01% | 907 |
|
|
2021
Q4 | $3.14M | Buy |
+134,429
| New | +$3.14M | 0.02% | 405 |
|
|
2020
Q4 | – | Sell |
-65,259
| Closed | -$2.69M | – | 1704 |
|
|
2020
Q3 | $2.69M | Sell |
65,259
-29,948
| -31% | -$1.23M | 0.08% | 153 |
|
|
2020
Q2 | $4.61M | Buy |
+95,207
| New | +$4.61M | 0.14% | 131 |
|